GLP-1 treatment linked to lower risk of hospitalization and death in older adults with fatty liver disease
A new Houston Methodist Research Institute study finds that older adults with metabolic dysfunction-associated steatotic liver disease (MASLD) who received GLP-1-based treatment experienced significantly lower risks of liver ...
20 hours ago
0
5









